For individuals battling Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a devastating condition, the arrival of this treatment and the formulated version represents a true advancement . These groundbreaking therapies preserve the transthyretin protein, halting its destructive build-up and reduci